Fig. 5From: Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic miceEffect of protein vaccination on Aβ proteins in T5x mice. Level of human Aβ42 (a, d), Aβ40 (b, e), and Aβ38 (c, f) peptides in brain soluble (a–c) and insoluble (d–f) extractions were analyzed by MSD assay. Lines represent average (*p ≤ 0.05; **p ≤ 0.01)Back to article page